MRNA Stock Analysis: Buy, Sell, or Hold?
MRNA - Moderna, Inc. Common Stock
$58.68
-5.28 (-8.26%)
▼
5d:
+17.57%
30d:
+21.95%
90d:
+14.21%
SELL
MODERATE Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 07, 2026
Smart Money Distribution
None View Scanner →
Strength: 10.0/10
Get Alerted When MRNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⚠️ CAUTION: MRNA is extended with warning signals. Consider taking profits or waiting for better entry.
⚠️ CAUTION: MRNA is extended with warning signals. Consider taking profits or waiting for better entry.
In-depth Analysis How we analyze
Valuation Analysis: MRNA is currently trading at $58.68, which is considered extended relative to its 30-day fair value range of $45.47 to $54.17.
Technical Outlook: Technically, MRNA is showing sideways momentum. Immediate support is located at $45.40, while resistance sits at $67.74. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $43.30. Given the valuation headwinds and technical position, caution is warranted at these levels.
Technical Outlook: Technically, MRNA is showing sideways momentum. Immediate support is located at $45.40, while resistance sits at $67.74. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $43.30. Given the valuation headwinds and technical position, caution is warranted at these levels.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$45.47 -
$54.17
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
30.0%
Protect Your Profits
Before you sell your MRNA shares, consider hedging with options to lock in your gains without triggering a tax event.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.3% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.3%)
- BEARISH: Trading 32.3% above Wall St target ($43.30)
Trading Range Analysis
30-Day Trading Range
$45.47 -
$54.17
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$45.40
Resistance Level
$67.74
Current Trend
Sideways
Technical data as of
Jun 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.54
Wall Street Target
$43.30
(-32.3%)
Revenue Growth (YoY)
260.2%
Earnings Growth (YoY)
-85.1%
Profit Margin
-143.6%
Share & Embed Analysis
Last updated: June 22, 2026 11:09 AM ET
Data refreshes hourly during market hours. Next update: 12:09 PM
Data refreshes hourly during market hours. Next update: 12:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRNA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Stephen Hoge
SELL
160009 shares
2026-02-23
Ro Khanna
BUY
2026-01-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 58 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 60 BUY |
Advanced MRNA Option Strategies
Professional options setups generated by AI based on today's MRNA price and gamma walls.
